Shearman & Sterling Advises Quest Diagnostics Incorporated on $750 Million Senior Notes Offering

Shearman & Sterling represented Quest Diagnostics Incorporated in connection with its registered offering of $750,000,000 aggregate principal amount of its 6.400% Senior Notes due 2033. Goldman Sachs & Co. LLC, Mizuho, Morgan Stanley, J.P. Morgan and Wells Fargo Securities acted as joint book-running managers for the offering.

Quest Diagnostics Incorporated is the world’s leading provider of diagnostic information services.

Content Disclaimer
This content was originally published by Shearman & Sterling before the A&O Shearman merger